vs
Side-by-side financial comparison of Grand Canyon Education, Inc. (LOPE) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Grand Canyon Education, Inc. is the larger business by last-quarter revenue ($308.1M vs $164.7M, roughly 1.9× PTC THERAPEUTICS, INC.). Grand Canyon Education, Inc. runs the higher net margin — 28.1% vs -82.0%, a 110.1% gap on every dollar of revenue. On growth, Grand Canyon Education, Inc. posted the faster year-over-year revenue change (5.3% vs -22.7%). Grand Canyon Education, Inc. produced more free cash flow last quarter ($122.9M vs $-36.6M). Over the past eight quarters, Grand Canyon Education, Inc.'s revenue compounded faster (5.9% CAGR vs -11.5%).
Grand Canyon Education, Inc. (GCE) is an American for-profit corporation that provides services to universities, specializing in program development, online education, and operational support. Formerly affiliated with Grand Canyon University (GCU), a Christian university in Arizona, GCE became a separate publicly traded company in 2008.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
LOPE vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $308.1M | $164.7M |
| Net Profit | $86.7M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 35.1% | -43.3% |
| Net Margin | 28.1% | -82.0% |
| Revenue YoY | 5.3% | -22.7% |
| Net Profit YoY | 5.9% | -104.8% |
| EPS (diluted) | $3.13 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $308.1M | $164.7M | ||
| Q3 25 | $261.1M | $211.0M | ||
| Q2 25 | $247.5M | $178.9M | ||
| Q1 25 | $289.3M | $1.2B | ||
| Q4 24 | $292.6M | $213.2M | ||
| Q3 24 | $238.3M | $196.8M | ||
| Q2 24 | $227.5M | $186.7M | ||
| Q1 24 | $274.7M | $210.1M |
| Q4 25 | $86.7M | $-135.0M | ||
| Q3 25 | $16.3M | $15.9M | ||
| Q2 25 | $41.5M | $-64.8M | ||
| Q1 25 | $71.6M | $866.6M | ||
| Q4 24 | $81.9M | $-65.9M | ||
| Q3 24 | $41.5M | $-106.7M | ||
| Q2 24 | $34.9M | $-99.2M | ||
| Q1 24 | $68.0M | $-91.6M |
| Q4 25 | 35.1% | -43.3% | ||
| Q3 25 | 6.9% | 1.4% | ||
| Q2 25 | 20.9% | -19.5% | ||
| Q1 25 | 30.4% | 82.5% | ||
| Q4 24 | 34.2% | -76.2% | ||
| Q3 24 | 20.2% | -27.7% | ||
| Q2 24 | 18.8% | -21.5% | ||
| Q1 24 | 30.8% | -21.6% |
| Q4 25 | 28.1% | -82.0% | ||
| Q3 25 | 6.2% | 7.5% | ||
| Q2 25 | 16.8% | -36.3% | ||
| Q1 25 | 24.8% | 73.7% | ||
| Q4 24 | 28.0% | -30.9% | ||
| Q3 24 | 17.4% | -54.2% | ||
| Q2 24 | 15.3% | -53.1% | ||
| Q1 24 | 24.8% | -43.6% |
| Q4 25 | $3.13 | $-1.63 | ||
| Q3 25 | $0.58 | $0.20 | ||
| Q2 25 | $1.48 | $-0.83 | ||
| Q1 25 | $2.52 | $10.04 | ||
| Q4 24 | $2.83 | $-0.85 | ||
| Q3 24 | $1.42 | $-1.39 | ||
| Q2 24 | $1.19 | $-1.29 | ||
| Q1 24 | $2.29 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $111.8M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $746.9M | $-205.3M |
| Total Assets | $992.3M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $111.8M | $1.9B | ||
| Q3 25 | $97.3M | $1.7B | ||
| Q2 25 | $192.3M | $2.0B | ||
| Q1 25 | $144.5M | $2.0B | ||
| Q4 24 | $324.6M | $1.1B | ||
| Q3 24 | $263.6M | $1.0B | ||
| Q2 24 | $241.3M | $1.1B | ||
| Q1 24 | $196.2M | $884.8M |
| Q4 25 | $746.9M | $-205.3M | ||
| Q3 25 | $758.0M | $-155.8M | ||
| Q2 25 | $778.0M | $-206.5M | ||
| Q1 25 | $780.7M | $-185.8M | ||
| Q4 24 | $783.9M | $-1.1B | ||
| Q3 24 | $764.1M | $-1.1B | ||
| Q2 24 | $759.2M | $-980.2M | ||
| Q1 24 | $759.4M | $-893.9M |
| Q4 25 | $992.3M | $2.9B | ||
| Q3 25 | $1.0B | $2.6B | ||
| Q2 25 | $1.0B | $2.6B | ||
| Q1 25 | $1.0B | $2.7B | ||
| Q4 24 | $1.0B | $1.7B | ||
| Q3 24 | $992.9M | $1.8B | ||
| Q2 24 | $992.7M | $1.9B | ||
| Q1 24 | $1.0B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $130.5M | $-34.3M |
| Free Cash FlowOCF − Capex | $122.9M | $-36.6M |
| FCF MarginFCF / Revenue | 39.9% | -22.3% |
| Capex IntensityCapex / Revenue | 2.5% | 1.4% |
| Cash ConversionOCF / Net Profit | 1.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | $238.6M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.5M | $-34.3M | ||
| Q3 25 | $-48.6M | $-66.3M | ||
| Q2 25 | $124.0M | $-58.3M | ||
| Q1 25 | $67.6M | $870.1M | ||
| Q4 24 | $135.8M | $-30.0M | ||
| Q3 24 | $-29.4M | $-77.0M | ||
| Q2 24 | $98.6M | $-71.5M | ||
| Q1 24 | $85.0M | $70.8M |
| Q4 25 | $122.9M | $-36.6M | ||
| Q3 25 | $-58.3M | $-69.7M | ||
| Q2 25 | $115.4M | $-59.6M | ||
| Q1 25 | $58.7M | $868.4M | ||
| Q4 24 | $126.1M | $-33.8M | ||
| Q3 24 | $-39.0M | $-77.5M | ||
| Q2 24 | $89.6M | $-78.8M | ||
| Q1 24 | $76.0M | $61.2M |
| Q4 25 | 39.9% | -22.3% | ||
| Q3 25 | -22.3% | -33.1% | ||
| Q2 25 | 46.6% | -33.3% | ||
| Q1 25 | 20.3% | 73.8% | ||
| Q4 24 | 43.1% | -15.8% | ||
| Q3 24 | -16.3% | -39.4% | ||
| Q2 24 | 39.4% | -42.2% | ||
| Q1 24 | 27.7% | 29.1% |
| Q4 25 | 2.5% | 1.4% | ||
| Q3 25 | 3.7% | 1.6% | ||
| Q2 25 | 3.5% | 0.7% | ||
| Q1 25 | 3.1% | 0.1% | ||
| Q4 24 | 3.3% | 1.8% | ||
| Q3 24 | 4.0% | 0.3% | ||
| Q2 24 | 3.9% | 4.0% | ||
| Q1 24 | 3.3% | 4.6% |
| Q4 25 | 1.50× | — | ||
| Q3 25 | -2.99× | -4.17× | ||
| Q2 25 | 2.98× | — | ||
| Q1 25 | 0.94× | 1.00× | ||
| Q4 24 | 1.66× | — | ||
| Q3 24 | -0.71× | — | ||
| Q2 24 | 2.83× | — | ||
| Q1 24 | 1.25× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
